HERAN Partners is a venture capital firm that focuses on investing in HealthTech ventures. The company provides funding and support for the next generation of healthcare technology companies.

HERAN Partners

HERAN PARTNERS is a Belgian-based investment fund founded by Annie Vereecken together with Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst within the sector of MedTech and Digital Health. With a clear focus on European HealthTech, the fund provides venture & growth capital accompanied by a strong network, expertise and mentorship to startups and scale-ups with a strong technology platform and market potential. We strive to have impact!

🙌 icometrix on track for big breakthrough in US 🙌

🎉 We, at HERAN Partners, are thrilled to announce Jeanne Kehren as LynxCare new CEO. Jeanne succeeds our visionary founder, Georges De Feu. 

As LynxCare continues to grow, we recognize the need for specialized experience and leadership to guide us through our next phase of development. Jeanne brings profound expertise in innovative healthcare data solutions and a proven track record of accelerating pharmaceutical innovation through technology.

Jeanne began her career at Novartis, enhancing R&D with cutting-edge technologies and data integration. She joined Sanofi in 2009, where she led major projects and later reshaped portfolios and strategies. In 2019, she joined Bayer as a Pharma Executive Committee member, heading Digital & Commercial Innovation, and in 2021, she also took on the role of Chief Information Officer Pharmaceuticals until the end of last year.

We are confident that Jeanne’s leadership will propel Lynxcare to new heights while continuing to deliver innovative health data solutions and drive success for our clients and partners. 

Please join us in welcoming Jeanne Kehren to LynxCare! 🌟
Robert Vassoyan Anne Mathieu Samantha J. Dries Hens , M.D. Christian Schütz

HERAN Partners will attend the HLTH Europe conference in Amsterdam next week!

Our colleagues Katleen Vandersmissen & Geoffrey D'hondt are looking forward to speaking with innovative players in the healthcare space, like-minded investors, and many other stakeholders! Reach out to connect with them!

#HLTHeurope #CreatingTheFutureOfHealthcare #VentureCapital #Amsterdam #HERANPartners

🎀HERAN Partners celebrates 𝐅𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐢𝐧𝐠 𝐬𝐮𝐜𝐜𝐞𝐬𝐬 for Think Pink!🎀

Our Managing Partner Katleen Vandersmissen, alongside a group of 40 incredible ladies, has completed a 𝟗𝟎𝟎𝐤𝐦 𝐫𝐚𝐜𝐞 𝐛𝐢𝐤𝐞 𝐫𝐢𝐝𝐞 in 1 week, from Pamplona to Santiago de Compostella! 🚴♀️

This inspiring journey was dedicated to 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐡𝐞 𝐟𝐢𝐠𝐡𝐭 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐛𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 𝐛𝐲 𝐫𝐚𝐢𝐬𝐢𝐧𝐠 𝐚𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐟𝐮𝐧𝐝𝐬 for Think Pink.

🎯Thanks to the efforts of these amazing women and 𝐘𝐎𝐔𝐑 generosity, the
𝐭𝐨𝐭𝐚𝐥 𝐚𝐦𝐨𝐮𝐧𝐭 𝐫𝐚𝐢𝐬𝐞𝐝 is more than 𝐄𝐔𝐑 𝟕𝟐.𝟐𝟎𝟎,𝟎𝟎! 🎯

A heartfelt thank you to everyone who contributed to this cause. We are proud to share that HERAN Partners 𝐡𝐚𝐬 𝐦𝐚𝐭𝐜𝐡𝐞𝐝 your 𝐝𝐨𝐧𝐚𝐭𝐞𝐝 𝐚𝐦𝐨𝐮𝐧𝐭 to Think Pink, amplifying the impact of your contributions.


#ThinkPink #breastcancer #awareness# #MakingADifference #charity

Our Founding Partner Herman Verrelst shares his insights on Startup Teams in this TenU podcast. Food for thought!

🎀 HERAN Partners 𝐬𝐮𝐩𝐩𝐨𝐫𝐭𝐬 Think Pink🎀 

Our Managing Partner Katleen Vandersmissen joins Team Camarilla for a bikeride from Pamplona to Santiago de Compostella, to support the fight against breast cancer.

HERAN Partners sponsors Team Camarilla for 𝐄𝐔𝐑 𝟏𝟎𝟎𝟎 & 𝐰𝐢𝐥𝐥 𝐦𝐚𝐭𝐜𝐡 𝐲𝐨𝐮𝐫 𝐝𝐞𝐩𝐨𝐬𝐢𝐭𝐞𝐝 𝐚𝐦𝐨𝐮𝐧𝐭 to Think Pink!

🚩 Make sure you select '𝐆𝐢𝐟𝐭'and mention '𝐊𝐚𝐭𝐥𝐞𝐞𝐧' in the message field when you sponsor, so we can match your deposited amount.



#thinkpink #breastcancer #awareness 

https://lnkd.in/ed5q3U8e

Our colleague Geoffrey D'hondt participated in the BVA | Belgian Venture Capital & Private Equity Association roundtable during which the #VC toolbox was discussed and key experiences were exchanged. Special thanks to Volta Ventures and Jan Alexander for organising this insightful session!

#CreatingTheFutureOfHealthcare #BVA #VC

📈 HERAN Partners CEO event: 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐂𝐥𝐚𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 by Vlerick Business School 📈

We had the pleasure to bring together the 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐭𝐞𝐚𝐦𝐬 𝐨𝐟 𝐨𝐮𝐫 𝐩𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 for the Executive Class Strategy Program hosted by Vlerick Business School. As part of the program, the attendees were immersed in ways to develop the right 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐟𝐨𝐫 𝐚 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬, 𝐢𝐧-𝐝𝐞𝐩𝐭𝐡 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐭𝐡𝐢𝐧𝐤𝐢𝐧𝐠 & 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐢𝐧𝐠, and 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬.

Special thanks to Martin Weiss & Ann Vanhie!

🙌 Mark Truesdale, PhD Steven Lauwers Kris Ver Donck
Wim Van Hecke Dirk Smeets Annemie Ribbens Jan Verheyden
Maurice Van Kerkhoven Tom De Caluwé Frederik Lenaerts
Georges De Feu Stephan Engelen Dries Hens , M.D.
Eva van Rikxoort, PhD Rick Philipsen Rita Priori
Valerie Morel Karien Pype Bérénice Wulbrecht
Marc Claesen Nico Verbeeck Wanqiu Zhang, PhD
Elise Pepermans Geert Baggerman Kurt Boonen Michael Ebner
Katleen Vandersmissen Herman Verrelst Joris Mortelmans Emke Goijens Geoffrey D'hondt Raf Roelands Laurens de Vries, MD 🙌

#MentoringEntrepreneurialTalent #CreatingtheFutureOfHealthcare #CollaborativeLearning #growth

HERAN Partners is attending #Medica and BIO.NRW 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐀𝐧𝐠𝐞𝐥 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬

Investment Director Raf Roelands and Analyst Laurens de Vries, MD are looking forward to connect with start-ups, investors and industry professionals!

Thank you BIO.NRW for inviting us!

Investment Manager Geoffrey D'hondt and Analyst Laurens de Vries, MD are looking forward to meeting other digital health innovators at Frontier’s Health in Rome.
 
Reach out to them via DM if you want to meet up!

#innovation #healthcare #venturecapital #digitalhealth

Metric
Company Name	HERAN Partners
Symbol
MSH ID	COM:HERANPARTNERS
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	BE
Stage
Employee Count
Website	heranpartners.com
LinkedIn	heran-partners
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HERA

COM:HERANPARTNERS

HERAN Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue